March 30, 2020
WTO

Brazil | Authorization for the export of chloroquine, hydroxychloroquine, and azithromycin and its salts devoted to the efforts against Covid-19.

Brazil South America

COVID-19 Pharma

Title of document
Resolution – RDC number 352, 20 March 2020 (5 page(s), in Portuguese)

Description
This Resolution establishes previous authorization for the export of chloroquine, hydroxychloroquine, and azithromycin and its salts devoted to the efforts against Covid-19.

Notifying member: Brazil

Notification: G/TBT/N/BRA/994

Objective tag
Protection of human health or safety

Documents

RDC_352_2020_COMP.pdf

Agency responsible
National Institute of Metrology, Quality and Technology (INMETRO) Telephone: +(55) 21 2145.3817 Telefax: +(55) 21 2563.5637 Email: barreirastecnicas@inmetro.gov.br Web-site: www.inmetro.gov.br/barreirastecnicas

Timing:

Submission: 27/03/2020
Reception: 27/03/2020
Distribution: 30/03/2020
Final date for comments: N/A
Proposed date of adoption: N/A

Brazil | Authorization for the export of chloroquine, hydroxychloroquine, and azithromycin and its salts devoted to the efforts against Covid-19.

Your substances

None

This news contains references also to other Substances

Related News

Automate your regulatory monitoring

or learn more about our plans

Brazil | Authorization for the export of chloroquine, hydroxychloroquine, and azithromycin and its salts devoted to the efforts against Covid-19.

Your substances

None

This news contains references also to other Substances

Related News